Phase 1b study to assess the safety, tolerability, and clinical activity of pamiparib in combination with temozolomide in patients with locally advanced or metastatic solid tumors.
Cancer Med
; 13(13): e7385, 2024 Jul.
Article
in En
| MEDLINE
| ID: mdl-38970256
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Benzimidazoles
/
Antineoplastic Combined Chemotherapy Protocols
/
Maximum Tolerated Dose
/
Temozolomide
/
Neoplasms
Limits:
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Med
Year:
2024
Document type:
Article
Affiliation country:
España
Country of publication:
Estados Unidos